OGTT检测在妊娠糖尿病筛查中的应用分析
|
摘要
目的探讨OGTT检测在妊娠糖尿病筛查中的应用和意义。方法选取我中心2015年1月~2016年6月进行妊娠期糖尿病筛查的孕妇1 723例为研究对象,进行OGTT试验,分析筛查结果。结果我中心1 723例产检孕妇实施OGTT检测后,筛查出妊娠糖尿病患者102例,阳性率为5.92%;其中35~42岁的高龄孕妇组中GDM的发病率高于其他年龄组;空腹血糖高于4.4 mmol/L组GDM的患病率高于空腹血糖小于4.4 mmol/L组。结论妊娠期进行糖尿病筛查具有重要意义,对妊娠期糖尿病患者进行系统管理,能够改善孕妇围产结局,值得推广。
Objective To investigate the application and significance of OGTT detection in the screening of gestational diabetes mellitus. Methods 1 723 pregnant women in our center from January 2015 to June 2016 were selected as the study subjects, and the results were analyzed by OGTT test. Results 1 723 cases of prenatal pregnant women after implementation of OGTT detection, screening of 102 cases of gestational diabetes, the positive rate was 5.92%; of which 35 to 42 years old women group the incidence of GDM was higher than other age groups; the prevalence of fasting blood glucose is higher than 4.4 mmol/L in group GDM was higher than that of fasting blood glucose less than 4.4 mmol/L group. Conclusion Gestational diabetes screening is of great significance, the system management of gestational diabetes patients, to improve the perinatal outcome of pregnant women, it is worth promoting.
Objective To investigate the application and significance of OGTT detection in the screening of gestational diabetes mellitus. Methods 1 723 pregnant women in our center from January 2015 to June 2016 were selected as the study subjects, and the results were analyzed by OGTT test. Results 1 723 cases of prenatal pregnant women after implementation of OGTT detection, screening of 102 cases of gestational diabetes, the positive rate was 5.92%; of which 35 to 42 years old women group the incidence of GDM was higher than other age groups; the prevalence of fasting blood glucose is higher than 4.4 mmol/L in group GDM was higher than that of fasting blood glucose less than 4.4 mmol/L group. Conclusion Gestational diabetes screening is of great significance, the system management of gestational diabetes patients, to improve the perinatal outcome of pregnant women, it is worth promoting.
引文
[1]黎肖梅.妊娠期糖尿病筛查与孕期保健的关系[J].医学理论与实践,2011,24(10):1183-1184.
[2]王燕芳,张璐莹.妊娠糖尿病筛查和干预的经济学评价综述[J].中国卫生事业管理,2015,32(12):953-956.
[3]黄梅霞,林丽琴.妊娠期糖耐量试验对妊娠糖尿病的临床意义[J].吉林医学,2010,31(22):3653-3654.
[4]曹艳丽,单忠艳.糖尿病的诊断标准:OGTT vs Hb A(1C)[J].药品评价,2011,8(1):4-5.
[5]谢海英.妊娠期糖尿病筛查与孕期保健的关系[J].中国药物经济学,2013,8(5):452-453.
[6]张金芝.妊娠期糖尿病筛查和治疗进展[J].海南医学,2013,24(S1):112-111.
[7]刘迎军,王俊臣,杜明贞,等.1 676例孕妇妊娠期糖尿病筛查结果分析[J].中国妇幼保健,2011,26(19):2920-2921.
[8]张眉花,韩雅菲,吴桂莲,等.妊娠期糖代谢异常发生率及高危因素的前瞻性对照分析[J].中国妇产科临床杂志,2007,8(3):181-184.
[9]戚小红,姬志娟,马杰,等.妊娠合并糖尿病对新生儿脐血C肽、胰岛素以及胰高血糖素水平的影响[J].中国儿童保健杂志,2008,16(3):284-286.
[10]时春艳,杨慧霞,董悦,等.对8 665例孕妇行妊娠期糖尿病筛查的临床研究[J].中华妇产科杂志,2003,38(3):136-139.
[2]王燕芳,张璐莹.妊娠糖尿病筛查和干预的经济学评价综述[J].中国卫生事业管理,2015,32(12):953-956.
[3]黄梅霞,林丽琴.妊娠期糖耐量试验对妊娠糖尿病的临床意义[J].吉林医学,2010,31(22):3653-3654.
[4]曹艳丽,单忠艳.糖尿病的诊断标准:OGTT vs Hb A(1C)[J].药品评价,2011,8(1):4-5.
[5]谢海英.妊娠期糖尿病筛查与孕期保健的关系[J].中国药物经济学,2013,8(5):452-453.
[6]张金芝.妊娠期糖尿病筛查和治疗进展[J].海南医学,2013,24(S1):112-111.
[7]刘迎军,王俊臣,杜明贞,等.1 676例孕妇妊娠期糖尿病筛查结果分析[J].中国妇幼保健,2011,26(19):2920-2921.
[8]张眉花,韩雅菲,吴桂莲,等.妊娠期糖代谢异常发生率及高危因素的前瞻性对照分析[J].中国妇产科临床杂志,2007,8(3):181-184.
[9]戚小红,姬志娟,马杰,等.妊娠合并糖尿病对新生儿脐血C肽、胰岛素以及胰高血糖素水平的影响[J].中国儿童保健杂志,2008,16(3):284-286.
[10]时春艳,杨慧霞,董悦,等.对8 665例孕妇行妊娠期糖尿病筛查的临床研究[J].中华妇产科杂志,2003,38(3):136-139.